Glucotrack, Inc. Signs Material Definitive Agreement

Ticker: GCTK · Form: 8-K · Filed: Feb 5, 2025 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateFeb 5, 2025
Risk Levelmedium
Pages5
Reading Time6 min
Key Dollar Amounts$0.001, $1.15, $3.03 m
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, corporate-action

TL;DR

Glucotrack signs a big deal, details TBD.

AI Summary

On February 4, 2025, Glucotrack, Inc. entered into a material definitive agreement. The filing does not disclose specific details of the agreement, the counterparty, or any associated financial figures. The company previously changed its name from Integrity Applications, Inc. in 2010 and GlucoTrack, Inc. in 2022.

Why It Matters

This filing indicates a significant new contract or partnership for Glucotrack, Inc., which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — The lack of specific details in the filing regarding the material definitive agreement introduces uncertainty about its nature and potential impact.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Glucotrack, Inc.?

The filing does not specify the nature of the material definitive agreement.

Who is the counterparty to the material definitive agreement?

The filing does not disclose the identity of the counterparty to the agreement.

Are there any financial terms or dollar amounts associated with this agreement?

The filing does not provide any specific financial terms or dollar amounts related to the agreement.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on February 4, 2025.

What was Glucotrack, Inc.'s previous name?

Glucotrack, Inc. was formerly known as GlucoTrack, Inc. and prior to that, Integrity Applications, Inc.

Filing Stats: 1,559 words · 6 min read · ~5 pages · Grade level 14 · Accepted 2025-02-05 09:00:16

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 5, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing